Floatz logo

MONOCLONAL ANTIBODY BC8

Bone Marrow Transplant

Actinium Pharmaceuticalsmonoclonal_antibodyPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

74 Active assets in the Bone Marrow Transplant cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The First Affiliated Hospital of Soochow University
Phase 3BBB
Busulphan
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BBB
FILGRASTIM
National Cancer Institute (NCI)
Phase 2/3BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
M.D. Anderson Cancer Center
Phase 2BBB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB

View all 50 →

Same molecule, other indications

MONOCLONAL ANTIBODY BC8 is also rated in:

acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →
Myelogenous LeukemiaDormant
B
Indicative ·
57 / 100
View asset →
myeloid leukemiaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →